De Ying Cao
Directeur/Membre du Conseil chez HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
Profil
De Ying Cao is an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Hebei Yipin Pharmaceutical Co., Ltd., and a Professor at Hebei Medical University.
Cao's former position was as an Independent Director at Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Postes actifs de De Ying Cao
| Sociétés | Poste | Début |
|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 30/12/2021 |
| Hebei Medical University | Corporate Officer/Principal | 08/08/2011 |
Hebei Yipin Pharmaceutical Co., Ltd.
 Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Directeur/Membre du Conseil | 01/05/2021 |
Anciens postes connus de De Ying Cao
| Sociétés | Poste | Fin |
|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
